Quantifying Patellar Tendon Microstructure Using DTI
Launched by UNIVERSITY OF WISCONSIN, MADISON · Apr 19, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called patellar tendinopathy, which affects the tendon in your knee. The researchers want to understand how a special type of imaging called diffusion tensor imaging (DTI) can provide insights into the structure of the patellar tendon and how it relates to traditional measures of knee function. Specifically, they are looking at whether areas of the tendon with known problems show different characteristics compared to healthy areas. This could help doctors better assess and treat knee injuries in the future.
To participate in this study, individuals need to be at least 18 years old and have a confirmed patellar tendon injury, along with current symptoms. Participants will undergo MRI and ultrasound imaging, perform tests to evaluate knee function, and fill out questionnaires about their condition. The study is currently recruiting participants of all genders, so if you or someone you know fits the criteria and is interested in helping advance our understanding of knee injuries, this could be a valuable opportunity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Have patellar tendon injury as confirmed through subjective report, clinical examination, and ultrasound by an experienced physical therapist
- • Patellar tendinopathy group must present with current symptoms of patellar tendinopathy
- • Control group must have no history of patellar tendon injury
- Exclusion Criteria:
- • Participants with a history of invasive procedures other than bone-patellar tendon-bone (BPTB) autograft harvest to the patellar tendon or extensor mechanism
- • Participants with history of contralateral BPTB autograft harvest, or ACLR using any other graft type
- • Participants with contraindications to MRI
- • Participants with contraindications to NMES
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Bryan Heiderscheit, PT, PhD
Principal Investigator
University of Wisconsin, Madison
Daniel Cobian, DPT, PhD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported